Dean Allman is a Principal at Blue Owl and member of the Direct Lending Investment Team. In his role he focuses on originating vendor and original equipment manufacturer (OEM) relationships to fund equipment leases and loans for the Commercial Solutions Group.  
  
Before joining Blue Owl, Dean was with Atalaya Capital Management, the predecessor firm to Blue Owl’s Alternative Credit team. Dean has been in the equipment finance industry for 30 years having worked at Sun Microsystems, GE Capital, Dell Financial, Cisco Capital, SunTrust, and Pathward Bank. 

Dean received his BS in Finance from the California State University Northridge.

Joe Alongi is a Senior Managing Director at Blue Owl and the Chief Financial Officer, Private Credit Funds and GP Strategic Capital. Joe is a member of the firm's Operating Committee as well as the Blue Owl Credit Operating and Valuation committees.

Prior to joining Blue Owl in 2018, Joe was a Director at Guggenheim Partners Investment Management, where he served as a Controller in the Private Commingled Fund Accounting Group and was responsible for the accounting and reporting for various Alternative Investment Funds and CLOs. Prior to that, Joe worked within the Financial Services practice of PwC where he specialized in audits of alternative investment funds and registered investment companies.

Joe received a BS in Accounting from Villanova University and is a licensed Certified Public Accountant in New York.

Kaitlin Alvarez is a Principal at Blue Owl and member of the Investor Operations Team. Based in Short Hills, she oversees all day-to-day functions, team development, strategic projects and technology initiatives for the Investor Operations team. Kaitlin also serves as co-chair of BOWE (Blue Owl for Women’s Empowerment).

Before joining Blue Owl, Kaitlin was the Senior Manager of Investor Services at Warburg Pincus, where she identified enhancements to procedures to improve efficiency and reduce risk. 

Kaitlin received both her MA and BA in Communication from Marist College.

Kerri Amato is a Managing Director at Blue Owl and member of the Compliance Team. Kerri Amato is a Managing Director at Blue Owl and member of the Compliance Team. Kerri serves as the Chief Compliance Officer of Blue Owl Securities LLC, the firm’s limited purpose broker-dealer and oversees the teams that manage Compliance Distribution, Global Entity and Information Reporting Compliance and Business Conduct Compliance.

Before joining Blue Owl, Kerri was a Managing Director at AQR Capital Management, LLC and served as the Chief Compliance Officer for AQR Investments, LLC. Kerri began her career as a Marketing Associate then transitioned to the Compliance Team at Arhnold & S. Bleichroeder Advisers LLC.

Kerri received her BBA in International Finance and Marketing from the University of Miami and holds a MBA in Finance and Marketing from Baruch College, Zicklin School of Business.

Beth Ambrosini is a Principal at Blue Owl and member of the Investor Operations Team. In her role, she serves as Product Owner for future private fund launches and provides ongoing operational support across the firm’s Healthcare, BODI, Alternative Credit, Credit, and Real Estate private funds. She also leads the operational implementation and launch of new funds in partnership with fund administrators and serves as a key point of contact for internal and external product-related matters.

Before joining Blue Owl, Beth was an Investor Operations Supervisor at Greenoaks LLC, where she supported investor operations for venture capital and growth equity funds. Earlier in her career, she held roles at ALPS Fund Services and GlobeOp Financial Services, both now part of SS&C, as well as HSBC and AllianceBernstein.

Beth received a Bachelor of Science in Finance from the University of Scranton.

Tim Anderson is a Managing Director at Blue Owl and member of the Healthcare Opportunities Investment Team. In his role, he focuses on investments in biotechnology, diagnostics, and digital medicine companies and serves on the Fund's Investment Committee.

Previously Tim was a co-founding member and Managing Director of Cowen Healthcare Investments, the predecessor to Blue Owl Healthcare Opportunities. Prior to his role at Cowen Healthcare Investments, Tim was a biotechnology investment banker at Cowen and Company.

He is currently a member of the Board of Directors of Windward Bio, Nuvig Therapeutics, Lycia Therapeutics, F2G, Anaveon, Autobahn Therapeutics and Scipher Medicine. Tim previously served as a Board Member or Board Observer of Tourmaline Bio, Vectiv Bio, Therachon, Precision Biosciences, Livongo Health, Cadent Therapeutics, Cullinan Oncology and Compass Therapeutics. 

Tim received a BA in both Economics and Government & Legal studies from Bowdoin College.

Joanna Antkowiak is a Managing Director at Blue Owl and member of the Private Wealth Team. In her role, she serves as the Head of International Client Solutions, focused on expansion of the private wealth product shelf across all regions outside of US, including product structuring, fund management, and other strategic initiatives.

Before joining Blue Owl, Joanna was at Blackstone, most recently as a Vice President on the Private Wealth Solutions team. Prior to that, she began her career as a Researcher at Dealogic on the Institutional Client Management team.

Joanna received her BA in International Business, with high honors, from the University of Westminster. She is a CAIA charterholder.

Tammer Badran is a Principal at Blue Owl and member of the Compliance Team. In his role, he focuses on all compliance matters regarding the Foreign Account Tax Compliance Act (FATCA), Common Reporting Standard (CRS) and Economic Substance (ES) globally for the firm.

Before joining Blue Owl, Tammer was a Director within Wealth Management Tax Operations at Morgan Stanley, focusing on the Stock Plan and Retirement businesses. Prior to that, he was a Senior Tax Analyst at Prudential Financial Inc. supporting Prudential’s Asset Management businesses (e.g., PGIM), where he specialized in Information Reporting and Withholding (IRW) and advised Prudential Asset Management businesses on FATCA & CRS tax compliance. Tammer began his career as a Tax Associate at Grant Thronton and a Tax Accountant at a boutique tax firm.

Tammer received his BA in Economics from Rutgers University.

Matt Baker is a Managing Director at Blue Owl and member of the Direct Lending Investment Team. In his role, he is focused on the origination and execution of investment opportunities for the direct lending business. 

Prior to joining Blue Owl, Matt was a Managing Director in the Private Credit Group at Goldman Sachs where he was involved in the group’s leveraged loan and mezzanine investing strategies. Prior to that, he worked at Pinnacle Agriculture Holdings as the Vice President of Business Development and Financial Planning and Analysis, Credit Suisse as a Vice President in the Financial Sponsors Group, SunTrust Robinson Humphrey as an Associate in the Syndicated and Leverage Finance Group and Lehman Brothers as an Analyst in the Private Wealth Management Group. 

Matt earned an MBA from Emory University’s Goizueta Business School and holds a BA in Economics from Boston College.

Brad Ballard is a Managing Director at Blue Owl and member of the Institutional Capital Team. In his role, he is responsible for institutional client development in Canada.

Before joining Blue Owl, he worked for I Squared, GCM Grosvenor, Partners Group, and BlackRock.

He received an MBA in Finance from York University and an H.B. Comm from McMaster University.